Trending Now
We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
{{ subpage.title }}
Participants make their way past the Notre-Dame Cathedral as they attend the 13th edition of the stand up Nautic Paddle race on the river Seine in Paris, France, December 1, 2024.
Hard Numbers: Notre Dame’s stones gleam after cleaning, Trump threatens yuge tariffs, Iceland gets new gov, Vaccine promises AIDS end
42,000: Workers restoring Paris’ Notre Dame Cathedral after the fire that ravaged it five years ago had to clean 42,000 square meters of stone. They used special techniques to minimize damage to the original masonry in the process and the results are stunning: See it for yourself: The medieval cathedral reopens to the public on Dec. 8.
100: President-elect Donald Trump on Saturday threatened to impose 100% tariffs on goods imported from BRICS countries (Brazil, Russia, India, China, and South Africa, as well Iran, Egypt, Ethiopia, and the UAE), should the organization try to issue its own currency or displace the dollar’s place in world trade. It’s an odd threat, as some members – namely Russia and Iran – are already so heavily sanctioned that trade with the US is non-existent, while others – Brazil, Egypt, and the UAE – are major US allies.
15: Iceland’s Social Democrats gained 15 seats in the Althing – one of the world’s oldest parliaments – and will unseat the ruling conservatives after seven years of power following Saturday’s snap election. It’s yet another example of the anti-establishment trend few democracies seem able to escape in this election-studded year.
2: A twice-yearly vaccine against HIV/AIDS has proven 100% effective against contracting the virus, which a UN report for World AIDS Day on Sunday called a “historic crossroads” in the fight to end the epidemic. Generic versions of the drug will be available in 120 low-income countries, mostly in Africa and Asia, but the manufacturer has not approved generic patents for Latin America, which may represent a crucial weak spot in distribution.